Lipoprotein(a), Cardiovascular Disease, and Contemporary Management

2013/10/30 by Terry A. Jacobson · 25 citations
Medicine · #Antiplatelet Therapy and Cardiovascular Diseases #Cholesterol #Disease #Familial hypercholesterolemia #Internal medicine #Lipoprotein #Lipoprotein(a) #Lipoproteins and Cardiovascular Health #Medicine #Niacin #Pharmacotherapy #Population #Residual risk #Risk factor #Statin

paper · doi:10.1016/j.mayocp.2013.09.003

openalex publication_date 2013/10/30 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Potential drug targets for calcific aortic valve disease. [europepmc]
• Clinician's guide to the updated ABCs of cardiovascular disease prevention. [europepmc]
• Plasma lipoprotein(a) levels are associated with mild renal impairment in type 2 diabetics independent of albuminuria. [europepmc]
• Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects. [europepmc]
• Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study. [europepmc]
• The relationship between Lp(a) and CVD outcomes: a systematic review. [europepmc]
• Association of Beta-2 Microglobulin with Inflammation and Dislipidemia in High-Flux Membrane Hemodialysis Patients. [europepmc]
• Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials. [europepmc]
• Risk of death from cardiovascular disease following breast cancer in Southeast Asia: a prospective cohort study. [europepmc]
• Lipoprotein (a), an independent cardiovascular risk marker. [europepmc]
• Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management. [europepmc]
• Body condition and adrenal glucocorticoid activity affects metabolic marker and lipid profiles in captive female elephants in Thailand. [europepmc]
• Lipoprotein(a) and Risk of Ischemic Stroke in the REGARDS Study. [europepmc]
• Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction. [europepmc]
• Obesity and dyslipidemia in patients with psoriasis: A case-control study. [europepmc]
• Serum Lipoprotein (a) levels in acute coronary syndrome; Comparison of younger and elderly patients with healthy controls. [europepmc]
• Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule. [europepmc]
• Prevalence and status of Lipoprotein (a) among Lebanese school children. [europepmc]
• Temporal bias in case-control design: preventing reliable predictions of the future. [europepmc]
• Cardiovascular Risk Assessment in the Older Athlete. [europepmc]
• Lipoprotein(a) Where Do We Stand? From the Physiopathology to Innovative Terapy. [europepmc]
• Characterization and modulation of surface charges to enhance extracellular vesicle isolation in plasma. [europepmc]
• Prevalence and Predictors of Insufficient Plasma Vitamin C in a Subtropical Region and Its Associations with Risk Factors of Cardiovascular Diseases: A Retrospective Cross-Sectional Study. [europepmc]
• Relationship between lipoprotein(a) and colorectal cancer among inpatients: a retrospective study. [europepmc]
• Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review. [europepmc]